[1]
Åkerblom A., Oldgren J., Latva-Rasku A., Johansson L., Lisovskaja V., Karlsson C., Oscarsson J. and Nuutila P. 2019. Effects of DAPAgliflozin on CARDiac substrate uptake, myocardial efficiency, and myocardial contractile work in type 2 diabetes patients—a description of the DAPACARD study. Upsala Journal of Medical Sciences. 124, 1 (Jan. 2019), 59–64. DOI:https://doi.org/10.1080/03009734.2018.1515281.